Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACUTE-PRAS: Prasugrel vs Clopidogrel in Acute Large Artery Atherothrombotic Stroke or High-Risk TIA
jRCTs031220079Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in brain infarction and transient ischaemic attack (TIA) comparing Prasugrel + aspirin with Clopidogrel + aspirin (2 arms). Started Jul 2022; status: completed.
02
Drugs
prasugrelclopidogrelaspirin
03
Conditions
brain infarctiontransient ischaemic attack (TIA)
Beyond the preview
Go deeper on jRCTs031220079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220079.